Viscoelastic solution

Details Viscoelastic solution Viscoelastic solution

1988-12-15

1991-05-07

Schain, Howard E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514 3, 514 12, 514 21, 514 57, 514912, 530324, A61K 3700, A61K 3726, A61K 3736

Patent

active

050137140

ABSTRACT:
Viscoelastic solution including a buffered solution, 0.01-8% chondroitin sulfate, 0.1-8% hydroxypropyl methylcellulose, pH adjusted to 6.0-8.0 at a osmolality between 200-400 mOsmol/L. The buffered solution can be HEPES buffered minimum essential media (MEM), phosphate buffer saline (PBS), buffered balanced salt solution, or TC199. A cell growth factor or cell growth supplement is included in the solution.

REFERENCES:
patent: 4713375 (1987-12-01), Lindstrom et al.
patent: 4713446 (1987-12-01), DeVore et al.
patent: 4717717 (1988-01-01), Finkenaur
Skelnik et al., Invest. Ophthalnol Visual Sci 28 (3 Suppl.), 1987, 326.
Eisner Trans. Ophthal Soc. U.K. (1983) 103, 247-253.

Affiliated with

Also associated with

Rating

Viscoelastic solution does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Viscoelastic solution, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Viscoelastic solution will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-939692